CLINICAL_TRIALS
trial_result
· 2018-10-02
Clinical Trial Update: BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis [Phase 2]
Summary
Phase II trial of rituximab in myasthenia gravis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Myasthenia Gravis | Phase 2 | Status: COMPLETED | Results posted: 2018-10-02